Abstract
Congenital heart disease (CHD) is the most common birth defect. It is due to dysfunction of the heart and great vessels during embryo development stage, or the channel was not closed after birth. This study focuses on investigating the influence of virus infection and medicine history during pregnancy on the incidence rate of CHD of fetus. We conducted a retrospective birth cohort study of infant born in the maternal and child health hospital of Fanyu district in Guangzhou. Five thousand three hundred eighty one cases with complete medical records, including mothers, fathers, and infants, were enrolled. The exposure history of mothers to virus and medicine from 6 months before pregnancy to prenatal examination was investigated, including mflu, mumps, measles, rubella, chickenpox, and hepatitis and antibiotics, tocolytic agent, anticonvulsants, antipyretic and analgesic, antitumor drug, folic acid supplement, and contraceptive. The relationship between virus infection and medicine history during pregnancy and CHD was analyzed. There was statistical difference between a normal group and a defected group in influenza infection and tocolytic agent and contraceptive pill. The exposure history to influenza and medicines, such as tocolytic agent and contraceptive pill, during pregnancy influenced the incidence rate of CHD of fetus.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Acs N, Banhidy F, Puho E, Czeizel AE (2005) Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Res A Clin Mol Teratol 73:989–996
Autti-Ramo I, Fagerlund A, Ervalahti N, Loimu L, Korkman M, Hoyme HE (2006) Fetal alcohol spectrum disorders in Finland: clinical delineation of 77 older children and adolescents. Am J Med Genet A 140:137–143
Burdan F, Szumilo J, Dudka J, Korobowicz A, Klepacz R (2006) Congenital ventricular septal defects and prenatal exposure to cyclooxygenase inhibitors. Braz J Med Biol Res 39:925–934
Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer SM, Gideon PS et al (2009) Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations. Paediatr Perinat Epidemiol 23:18–28
Czeizel AE, Puho EH, Acs N, Banhidy F (2007) High fever-related maternal diseases as possible causes of multiple congenital abnormalities: a population-based case-control study. Birth Defects Res A Clin Mol Teratol 79:544–551
Feldkamp ML, Meyer RE, Krikov S, Botto LD (2010) Acetaminophen use in pregnancy and risk of birth defects: findings from the National Birth Defects Prevention Study. Obstet Gynecol 115:109–115
Kallen BA, Otterblad OP (2003) Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 17:255–261
Kallen BA, Otterblad Olausson P, Danielsson BR (2005) Is erythromycin therapy teratogenic in humans? Reprod Toxicol 20:209–214
Lin KJ, Mitchell AA, Yau WP, Louik C, Hernandez-Diaz S (2013) Safety of macrolides during pregnancy. Am J Obstet Gynecol 208:221 e1-8
Nora JJ (1968) Multifactorial inheritance hypothesis for the etiology of congenital heart diseases. The genetic-environmental interaction. Circulation 38:604–617
Oberlander TF, Warburton W, Misri S, Riggs W, Aghajanian J, Hertzman C (2008) Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Reprod Toxicol 83:68–76
Oster ME, Riehle-Colarusso T, Alverson CJ, Correa A (2011) Associations between maternal fever and influenza and congenital heart defects. J Pediatr 158:990–995
Oster ME, Riehle-Colarusso T, Correa A (2010) An update on cardiovascular malformations in congenital rubella syndrome. Birth Defects Res A Clin Mol Teratol 88:1–8
Rosenberg HS (1987) Cardiovascular effects of congenital infections. Am J Cardiovasc Pathol 1:147–156
Shi H, Yang S, Liu Y, Huang P, Lin N, Sun X et al (2015) Study on environmental causes and SNPs of MTHFR, MS and CBS genes related to congenital heart disease. PLoS One 10:e0128646
Smith T, Rajakaruna C, Caputo M, Emanueli C (2015) MicroRNAs in congenital heart disease. Ann Transl Med 3:333
van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ et al (2011) Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 58:2241–2247
Wang X, Li P, Chen S, Xi L, Guo Y, Guo A et al (2014) Influence of genes and the environment in familial congenital heart defects. Mol Med Rep 9:695–700
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Responsible editor: Philippe Garrigues
Rights and permissions
About this article
Cite this article
Liang, Q., Gong, W., Zheng, D. et al. The influence of maternal exposure history to virus and medicine during pregnancy on congenital heart defects of fetus. Environ Sci Pollut Res 24, 5628–5632 (2017). https://doi.org/10.1007/s11356-016-8198-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11356-016-8198-4